Back to FA Focus Advisor Solutions, LLC
NKTR
2 quarters
Position history for FAFocus Advisor Solutions, LLC's holdings in Nektar Therapeutics
As of its Q1 2025 13F, Focus Advisor Solutions held 19,433 shares of NKTR (Nektar Therapeutics), worth $13,218.
Final Value
$0
Final Shares
0
Total Value Change
-$13,218
Total Shares Change
-19,433
Quarter-by-Quarter History